Haivya Demonstrates Programmable Bioacoustic Control Across Seven Plant Species

DESERT HOT SPRINGS, CA - Haivya Inc. has released cross species research showing that  its patent-pending Bioacoustic Cultivation and Communication Protocol (BCCP) produced  distinct, measurable plant responses across seven species and four plant families –  without added chemicals or gene editing.  

Most strikingly, genetically uniform plants exposed to two different BCCP protocols  developed predictably different outcomes. One protocol produced 42% greater yield,  while another produced 59% greater yield, 21.5% higher potency, a 14.2% faster cycle  and reduced water consumption compared to controls - all from the same genetics,  under matched conditions.  

"This is not a yield hack for a single crop," said Haivya Founder and Chief Scientist Andrea  Ott-Dahl. "It is evidence of a programmable biological platform. We are not simply  stimulating plants – we are selecting an outcome and designing the protocol towards it.”  

What makes BCCP different? Prior acoustic stimulation research has documented  isolated plant responses to single stimuli. BCCP takes a different approach: a structured  protocol that delivers species-specific bioacoustic signaling, with outcomes shaped by  both protocol design and each cultivar’s own biology.  

“With larger commercial validation, BCCP has the potential to become one of the most  meaningful non-genetic plant optimization platforms since modern biotechnology,” said  COO Keston Ott-Dahl.  

Independent validation. In a 100-plant propagation trial run and statistically analyzed by  Dr. Allison Justice (Ph.D., Clemson University), BCCP-treated hemp clones showed a  25.6% improvement in rooting scores over untreated controls (F=4.45, p=0.0057) in one  cultivar, while a second cultivar showed a directional advantage in lateral branching. In a  separate 36-plant independently observed validation trial analyzed by Dr. Robert Flannery  (Ph.D., UC Davis), BCCP-treated plants of a high-value specialty crop produced 90% more  total sellable biomass and 120.9% more premium flower than matched controls, using  less water per gram of output while maintaining equivalent biochemical potency, all  confirmed at p<0.0001.

Gains across every species. Across every species evaluated, BCCP-treated plants  developed enhanced root systems and greater lateral branching from the earliest  developmental stages – structural advantages that preceded and supported the yield  outcomes at harvest ranging from 29% to more than 100% depending on species and  protocol configuration. Earlier and more uniform reproductive transition was also  documented across multiple species, a finding with direct implications for growers where  predictable, synchronized harvest reduce cost and risk. In soybean, one of the world’s  most widely grown food commodities, BCCP plants reached reproductive maturity faster  and more uniformly than controls, with a 46% greater pod count at the trial’s early  benchmark. In basil, BCCP accelerated flowering and produced 45.6% greater biomass  over controls and in jalapeño peppers, this translated to a 171% increase in fruit count over  untreated controls.  

Biochemical pigment pathway activation across multiple species. In those same  pepper plants, and across basil, lemon balm, peppermint, spearmint, and a high-value  specialty crop, Haivya documented increased anthocyanin expression – an antioxidant  pigment compound and marker of biochemical pathway engagement – in BCCP-treated  plants, with no comparable expression in untreated controls. In bell pepper, Haivya went  further, demonstrating it could switch a single fruit's pigmentation on and off by changing  the protocol alone – cycling the fruit between deep purple expression and its typical  ripening color, with a full shift occurring in as little as 24 hours. Together, the findings  suggest BCCP can engage a shared biological response mechanism across diverse  species and direct it.  

Full trial data and methodology published on ResearchGate, and a condensed brief is  available on the company's website.  

Haivya has filed a U.S. non-provisional patent with five supporting provisional filings on the  BCCP platform and is pursuing collaborative partnerships across food, medicinal,  industrial crop, and climate applications. 

Keston Ott-Dahl  

HAIVYA, Inc  

+1 925-566-4353  

keston@haivya.com 

Visit us on social media:  

LinkedIn